Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis

Abstract Background Curculigoside is a natural phenolic glycoside compound produced by Curculigo orchioides Gaertn. This study aimed to explore the effects of curculigoside in promoting the osteogenic differentiation of adipose-derived stem cells (ADSCs) as well as the underlying mechanism. Methods...

Full description

Bibliographic Details
Main Authors: Wei-Li You, Zheng-Long Xu
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-021-02389-3
_version_ 1811185841554325504
author Wei-Li You
Zheng-Long Xu
author_facet Wei-Li You
Zheng-Long Xu
author_sort Wei-Li You
collection DOAJ
description Abstract Background Curculigoside is a natural phenolic glycoside compound produced by Curculigo orchioides Gaertn. This study aimed to explore the effects of curculigoside in promoting the osteogenic differentiation of adipose-derived stem cells (ADSCs) as well as the underlying mechanism. Methods ADSCs were treated with curculigoside at different concentrations (0 μmol/L, 1 μmol/L, 2.5 μmol/L, 5 μmol/L, 10 μmol/L, and 20 μmol/L), and cell viability was assessed by CCK-8 assay. Then, the alkaline phosphatase (ALP) activity was determined, and alizarin red S (ARS) staining was performed to measure the extracellular mineralization of curculigoside. Information about protein-chemical interactions is provided by the search tool for interactions of chemicals (STITCH) database. Then, LY294002 was administered to explore the mechanism by which curculigoside promotes the osteogenic differentiation of ADSCs. Western blot assays were performed to assess changes in the expression of osteogenic-related markers and the phosphorylation of PI3K and AKT. Finally, we established an ovariectomized (OVX)-induced osteoporosis mouse model and administered curculigoside to explore the effects of curculigoside in preventing bone loss in vivo. Results The CCK-8 assay indicated that curculigoside did not induce cytotoxicity at a concentration of 5 μmol/L after 48 h. The ALP and ARS results revealed that the induced group had higher ALP activity and calcium deposition than the control group. Moreover, the curculigoside group exhibited increased biomineralization, ALP activity, and ARS staining compared to the induced and control groups, and these effects were partially inhibited by LY294002. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated that the target genes of curculigoside were mainly involved in the PI3K-Akt signaling pathway. PCR and western blot analysis showed that the expression of RUNX2, ALP, and Osterix was upregulated in curculigoside-treated ADSCs, but this effect was partially reversed by the PI3K inhibitor LY294002. Moreover, the curculigoside-treated group exhibited significantly increased phosphorylation of AKT to P-AKT compared with the osteogenic induction group. After treatment with curculigoside, the mice had a higher bone volume than the OVX mice, suggesting partial protection from cancellous bone loss. In addition, when LY294002 was added, the protective effects of curculigoside could be neutralized. Conclusions Curculigoside could induce the osteogenic differentiation of ADSCs and prevent bone loss in an OVX model through the PI3K/Akt signaling pathway.
first_indexed 2024-04-11T13:37:11Z
format Article
id doaj.art-08e76b60169f4ec8966dbc4bac099a9d
institution Directory Open Access Journal
issn 1749-799X
language English
last_indexed 2024-04-11T13:37:11Z
publishDate 2021-04-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj.art-08e76b60169f4ec8966dbc4bac099a9d2022-12-22T04:21:26ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2021-04-011611910.1186/s13018-021-02389-3Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosisWei-Li You0Zheng-Long Xu1Department of Pharmacy, The First People’s Hospital of LianyungangDepartment of Pharmacy, Xinghua City People’s HospitalAbstract Background Curculigoside is a natural phenolic glycoside compound produced by Curculigo orchioides Gaertn. This study aimed to explore the effects of curculigoside in promoting the osteogenic differentiation of adipose-derived stem cells (ADSCs) as well as the underlying mechanism. Methods ADSCs were treated with curculigoside at different concentrations (0 μmol/L, 1 μmol/L, 2.5 μmol/L, 5 μmol/L, 10 μmol/L, and 20 μmol/L), and cell viability was assessed by CCK-8 assay. Then, the alkaline phosphatase (ALP) activity was determined, and alizarin red S (ARS) staining was performed to measure the extracellular mineralization of curculigoside. Information about protein-chemical interactions is provided by the search tool for interactions of chemicals (STITCH) database. Then, LY294002 was administered to explore the mechanism by which curculigoside promotes the osteogenic differentiation of ADSCs. Western blot assays were performed to assess changes in the expression of osteogenic-related markers and the phosphorylation of PI3K and AKT. Finally, we established an ovariectomized (OVX)-induced osteoporosis mouse model and administered curculigoside to explore the effects of curculigoside in preventing bone loss in vivo. Results The CCK-8 assay indicated that curculigoside did not induce cytotoxicity at a concentration of 5 μmol/L after 48 h. The ALP and ARS results revealed that the induced group had higher ALP activity and calcium deposition than the control group. Moreover, the curculigoside group exhibited increased biomineralization, ALP activity, and ARS staining compared to the induced and control groups, and these effects were partially inhibited by LY294002. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated that the target genes of curculigoside were mainly involved in the PI3K-Akt signaling pathway. PCR and western blot analysis showed that the expression of RUNX2, ALP, and Osterix was upregulated in curculigoside-treated ADSCs, but this effect was partially reversed by the PI3K inhibitor LY294002. Moreover, the curculigoside-treated group exhibited significantly increased phosphorylation of AKT to P-AKT compared with the osteogenic induction group. After treatment with curculigoside, the mice had a higher bone volume than the OVX mice, suggesting partial protection from cancellous bone loss. In addition, when LY294002 was added, the protective effects of curculigoside could be neutralized. Conclusions Curculigoside could induce the osteogenic differentiation of ADSCs and prevent bone loss in an OVX model through the PI3K/Akt signaling pathway.https://doi.org/10.1186/s13018-021-02389-3Adipose-derived stem cellsCurculigosidePI3K/Akt signaling pathwayOsteoporosis
spellingShingle Wei-Li You
Zheng-Long Xu
Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis
Journal of Orthopaedic Surgery and Research
Adipose-derived stem cells
Curculigoside
PI3K/Akt signaling pathway
Osteoporosis
title Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis
title_full Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis
title_fullStr Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis
title_full_unstemmed Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis
title_short Curculigoside promotes osteogenic differentiation of ADSCs to prevent ovariectomized-induced osteoporosis
title_sort curculigoside promotes osteogenic differentiation of adscs to prevent ovariectomized induced osteoporosis
topic Adipose-derived stem cells
Curculigoside
PI3K/Akt signaling pathway
Osteoporosis
url https://doi.org/10.1186/s13018-021-02389-3
work_keys_str_mv AT weiliyou curculigosidepromotesosteogenicdifferentiationofadscstopreventovariectomizedinducedosteoporosis
AT zhenglongxu curculigosidepromotesosteogenicdifferentiationofadscstopreventovariectomizedinducedosteoporosis